ORINASE 1GM 1 G
TOLBUTAMIDE : 1 G · DIN 00012610 · HOECHST CANADA INC.
Health Canada status: CANCELLED POST MARKET
What is ORINASE 1GM?
ORINASE 1GM 1 G contains TOLBUTAMIDE : 1 G. It is listed in the Health Canada Drug Product Database under DIN 00012610, held by HOECHST CANADA INC., supplied as TABLET for ORAL administration. Health Canada currently lists it as cancelled post market, status dated 28-Feb-1997. Nexara Health is a licensed Canadian wholesale distributor (DEL 3-002896-A) and can source this product for hospitals, pharmacies and clinics. Availability and lead time are confirmed per order.
Product details and regulatory record
| DIN | 00012610 |
|---|---|
| Brand name | ORINASE 1GM |
| Generic / active ingredient | TOLBUTAMIDE : 1 G |
| Manufacturer | HOECHST CANADA INC. |
| Strength | 1 G |
| Dosage form | TABLET |
| Route of administration | ORAL |
| Schedule | Prescription |
| ATC code | A10BB03 TOLBUTAMIDE |
| AHFS class | 68:20.20 |
| Biosimilar | No |
| Health Canada status | CANCELLED POST MARKET |
| Status date | 28-Feb-1997 |
| Original market date | 1966-12-31 00:00:00 |
How is this product identified?
Purchase orders, customs paperwork and tender documents each ask for a different identifier, and a DIN written without its leading zeros is the single most common reason an order line fails to match. Every form Nexara accepts for this product is listed here.
| DIN (8-digit, as used in Nexara ordering) | 00012610 |
|---|---|
| DIN (unpadded, as printed on some documents) | 12610 |
| Brand name | ORINASE 1GM |
| Active ingredient / INN | TOLBUTAMIDE : 1 G |
| ATC code | A10BB03 |
| ATC anatomical main group | A — Alimentary tract and metabolism |
| ATC therapeutic subgroup | A10 |
| AHFS class | 68:20.20 |
| Health Canada schedule | Prescription |
| Biosimilar biologic | No |
| Market authorization holder | HOECHST CANADA INC. |
Which pack is which?
| Strength on the label | 1 G |
|---|---|
| Dosage form | TABLET |
| Route | ORAL |
One DIN can cover more than one pack size, and the pack — not the DIN — is what gets priced, shipped and invoiced. Before an order line is unambiguous Nexara needs the strength, the pack size and the presentation.
What can be used instead?
Other Canadian products sharing ATC code A10BB03 TOLBUTAMIDE. 0 of 7 DINs in this group are currently marketed — marketed products are listed first, because that is what can actually be bought. These tables describe supply, not clinical equivalence: substitution rests with the prescriber or pharmacist, and interchangeability is determined provincially.
| Product | Strength | Form | Manufacturer | Health Canada status | DIN |
|---|---|---|---|---|---|
| MOBENOL TABLETS 500MG | 500 MG | TABLET | CARTER-HORNER CORP. | CANCELLED POST MARKET | DIN 00013889 |
| NOVO-BUTAMIDE 500MG | 500 MG | TABLET | NOVOPHARM LIMITED | CANCELLED POST MARKET | DIN 00021849 |
| ORINASE 0.5GM | 500 MG | TABLET | HOECHST CANADA INC. | CANCELLED POST MARKET | DIN 00012602 |
| TOLBUTAMIDE | 500 MG | TABLET | AA PHARMA INC | DORMANT | DIN 00312762 |
| TOLBUTAMIDE TAB 500MG | 500 MG | TABLET | PRO DOC LIMITEE | CANCELLED POST MARKET | DIN 00156663 |
| TOLBUTAMIDE TAB 500MG | 500 MG | TABLET | DUCHESNAY INC | CANCELLED POST MARKET | DIN 00431168 |
Can this still be bought in Canada?
No. This Drug Identification Number is cancelled post market in Health Canada's Drug Product Database, so the product is no longer authorized for sale in Canada and Nexara does not supply it. This page is kept as a regulatory record.
If you are looking for a current equivalent, the alternatives above list every product sharing this therapeutic class, with the marketed ones first. Ask us to source an alternative
Ordering questions
Who can buy this from Nexara?
Licensed entities only. Nexara holds Health Canada establishment licence DEL 3-002896-A and ships only to a licensed address.
Is there a minimum order?
Yes, set per product line and per pack multiple rather than on the order total, so you are never asked to buy a part-pack. The minimum for this line is confirmed with your quote.
What is the lead time?
Confirmed per order at quotation, and it depends on current stock position and whether the product is in shortage.
Can Nexara supply this for a clinical trial?
Yes — comparator and background-therapy supply, including sourcing from other markets where a Canadian pack will not satisfy the protocol. Clinical trial supply.